(Q35114601)

6 August 2017

title

Fluconazole penetration in cerebral parenchyma in humans at steady state (English)

1 reference

6 August 2017

1 reference

Thaler F

1

1 reference

6 August 2017

Bernard B

2

1 reference

6 August 2017

Tod M

3

1 reference

6 August 2017

Jedynak CP

4

1 reference

6 August 2017

Petitjean O

5

1 reference

6 August 2017

Derome P

6

1 reference

6 August 2017

Loirat P

7

1 reference

6 August 2017

language of work or name

English

0 references

publication date

1 May 1995

1 reference

Antimicrobial Agents and Chemotherapy

6 August 2017

published in

1 reference

6 August 2017

volume

39

1 reference

6 August 2017

issue

5

1 reference

6 August 2017

page(s)

1154-1156

1 reference

Fungal infections in solid-organ transplantation

6 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162699

Pharmacokinetics of 18F-labeled fluconazole in healthy human subjects by positron emission tomography

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162699

Pharmacokinetics and bioavailability of fluconazole in patients with AIDS.

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162699

Susceptibility testing of fungi: current status of the standardization process

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162699

Cryptococcal disease in patients with the acquired immunodeficiency syndrome. Diagnostic features and outcome of treatment

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162699

Antifungal susceptibility tests

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162699

Pharmacokinetic evaluation of UK-49,858, a metabolically stable triazole antifungal drug, in animals and humans

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162699

Oral fluconazole therapy for patients with acquired immunodeficiency syndrome and cryptococcosis: experience with 22 patients.

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162699

Pharmacokinetics of fluconazole in cerebrospinal fluid and serum in human coccidioidal meningitis

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162699

Pharmacokinetics and tissue penetration of fluconazole in rabbits

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162699

Fluconazole in the treatment of persistent coccidioidomycosis

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162699

Fluconazole compared with amphotericin B plus flucytosine for cryptococcal meningitis in AIDS. A randomized trial

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162699

Fluconazole. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in superficial and systemic mycoses

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162699

A placebo-controlled trial of maintenance therapy with fluconazole after treatment of cryptococcal meningitis in the acquired immunodeficiency syndrome. California Collaborative Treatment Group

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162699

Fluconazole therapy for chronic disseminated candidiasis in patients with leukemia and prior amphotericin B therapy

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162699

Hepatosplenic candidiasis: successful treatment with fluconazole

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162699

Use of high-dose fluconazole as salvage therapy for cryptococcal meningitis in patients with AIDS.

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162699

In vitro models for studying toxicity of antifungal agents

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162699

Cryptococcal meningitis in patients with AIDS

9 July 2018

1 reference

12 December 2020

Fluconazole penetration into cerebrospinal fluid in humans

1 reference

12 December 2020

Infections with Cryptococcus neoformans in the acquired immunodeficiency syndrome

1 reference

12 December 2020

Cryptococcal intracerebral mass lesions: the role of computed tomography and nonsurgical management

1 reference

12 December 2020

The disposition and metabolism of [14C]fluconazole in humans

1 reference

12 December 2020

Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis. The NIAID Mycoses Study Group and the AIDS Clinical Trials Group

1 reference

12 December 2020

A controlled trial of fluconazole or amphotericin B to prevent relapse of cryptococcal meningitis in patients with the acquired immunodeficiency syndrome. The NIAID AIDS Clinical Trials Group and Mycoses Study Group

1 reference

12 December 2020

Fluconazole therapy for coccidioidal meningitis. The NIAID-Mycoses Study Group

1 reference

12 December 2020

Identifiers

DOI

10.1128/AAC.39.5.1154

1 reference

6 August 2017

1 reference

6 August 2017

1 reference